BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 689042)

  • 1. Role of virus for the induction of myasthenia gravis.
    Smith CI; Hammarström L; Berg JV
    Eur Neurol; 1978; 17(4):181-7. PubMed ID: 689042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attempted isolation of viruses from myasthenia gravis thymus.
    Klavinskis LS; Willcox HN; Richmond JE; Newsom-Davis J
    J Neuroimmunol; 1986 Jun; 11(4):287-99. PubMed ID: 3519670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myasthenia gravis following viral infection.
    Korn IL; Abramsky O
    Eur Neurol; 1981; 20(6):435-9U. PubMed ID: 7308244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA antigens and myasthenia gravis in north India.
    Mehra NK; Ahuja GK; Taneja V; Vaidya MC
    J Neurol Neurosurg Psychiatry; 1983 Apr; 46(4):361-4. PubMed ID: 6842252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible role of HLA-B8 antigen as a genetic marker of autoimmune thrombocytopenia in a patient with myasthenia gravis.
    Remuzzi G; Misiani R; Livio M; dall'Olio A; Donati MB; de Gaetano G
    Thromb Haemost; 1977 Aug; 38(2):593-4. PubMed ID: 413208
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic factors in myasthenia gravis: a family study.
    Kerzin-Storrar L; Metcalfe RA; Dyer PA; Kowalska G; Ferguson I; Harris R
    Neurology; 1988 Jan; 38(1):38-42. PubMed ID: 3336461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Segregation of HLA haplotypes in 100 families with a myasthenia gravis patient.
    van den Berg-Loonen EM; Nijenhuis LE; Engelfriet CP; Feltkamp TE; van Rossum AL; Oosterhuis HJ
    J Immunogenet; 1977 Oct; 4(5):331-40. PubMed ID: 925350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA, anti-DNA, and complement in myasthenia gravis.
    Christiansen FT; Houliston JB; Dawkins RL
    Muscle Nerve; 1978; 1(6):467-70. PubMed ID: 757869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial autoimmune myasthenia gravis.
    Tan JH; Ho KH
    Singapore Med J; 2001 Apr; 42(4):178-9. PubMed ID: 11465320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA antigens and susceptibility to myasthenia gravis.
    Matej H; Nowakowska B; Kałamarz M; Paradowski B; Podemski R; Brzecki A
    Arch Immunol Ther Exp (Warsz); 1987; 35(6):795-801. PubMed ID: 3508039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent transverse myelitis, myasthenia gravis, and autoantibodies.
    Lindsey JW; Albers GW; Steinman L
    Ann Neurol; 1992 Sep; 32(3):407-9. PubMed ID: 1416813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Histocompatibility antigens in childhood myasthenia].
    Uhrynowska M
    Neurol Neurochir Pol; 1987; 21(2):119-24. PubMed ID: 3477704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunogenetics of myasthenia gravis. Significance of HLA-, complement and Cm gene systems for clinical and immunologic parameters].
    Grosse-Wilde H; Toyka KV; Besinger UA; Doxiadis I; Heininger K; Hömberg M; Hömberg V; Hohlfeld R; Fateh-Moghadam A; Jungwirth J; Kreeb G; Vögeler U
    Dtsch Med Wochenschr; 1983 May; 108(18):694-700. PubMed ID: 6839994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-A, -B, -C and -D antigens in male patients with myasthenia gravis.
    Säfwenberg J; Hammarström L; Lindblom JB; Matell G; Möller E; Osterman PO; Smith CI
    Tissue Antigens; 1978 Aug; 12(2):136-42. PubMed ID: 705769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFNA-AS1 regulates CD4
    Luo M; Liu X; Meng H; Xu L; Li Y; Li Z; Liu C; Luo YB; Hu B; Xue Y; Liu Y; Luo Z; Yang H
    Clin Immunol; 2017 Oct; 183():121-131. PubMed ID: 28822831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.
    Dönmez B; Ozakbas S; Oktem MA; Gedizlioglu M; Coker I; Genc A; Idiman E
    Hum Immunol; 2004 Jul; 65(7):752-7. PubMed ID: 15301866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The autoimmune spectrum of myasthenia gravis: a Swedish population-based study.
    Fang F; Sveinsson O; Thormar G; Granqvist M; Askling J; Lundberg IE; Ye W; Hammarström L; Pirskanen R; Piehl F
    J Intern Med; 2015 May; 277(5):594-604. PubMed ID: 25251578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA antigens and immunoglobulin allotypes in myasthenia gravis.
    Apolostolski S; Susaković N; Lavrnić S; Stolić I; Trikić R
    Neurologija; 1987; 36(1-4):41-9. PubMed ID: 3509808
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlation between acetylcholine receptor antibody titer and HLA-B8 and HLA-DRw3 antigens in myasthenia gravis.
    Keesey J; Naeim F; Lindstrom J; Zeller E; Herrmann C; Walford R
    Trans Am Neurol Assoc; 1978; 103():188-90. PubMed ID: 757055
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of complement C3b/C4b receptors (CR1) on erythrocytes from patients with myasthenia gravis.
    Vedeler CA; Gilhus NE; Matre R
    Acta Neurol Scand; 1990 Oct; 82(4):259-62. PubMed ID: 2148662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.